Cellular RNA cleanup crew protects blood stem cells from DNA damage and lymphoma risk

Stem cells that renew blood throughout life must preserve their genome for decades. Accumulated DNA damage in hematopoietic stem cells (HSCs) is a recognized contributor to aging-related decline in blood production and to blood cancers, so understanding how HSCs avoid damage matters for longevity research.

The researchers focused on a specific threat: pervasive transcription generates many non-functional nascent RNAs, which can hybridize with DNA to form R loops and cause DNA breaks. They investigated the nuclear exosome targeting (NEXT) complex, an adaptor that directs these RNAs to the RNA exosome for degradation. They deleted ZCCHC8, a core NEXT subunit, specifically in the hematopoietic system.

Loss of ZCCHC8 impaired HSC self-renewal. The mutant HSCs showed more DNA lesions and upregulated DNA repair pathways, which the authors attribute to accumulated R loops. The authors also report that ZCCHC8 is often dysregulated in diffuse large B cell lymphoma (DLBCL) and that this is associated with poor clinical outcomes.

The work suggests that clearing aberrant RNA is a built-in defense of stem cell genome stability, adding RNA surveillance to the list of mechanisms that may influence stem cell aging. It also points to NEXT as a potential therapeutic target in DLBCL, though how to target it is unclear.

Caveats: only the abstract was available, so details on models, sample sizes, and methods are unknown. The stem cell findings appear to come from genetic deletion in mice, which may not reflect normal aging or human physiology. The DLBCL link is an association, and no treatment has been tested. Whether enhancing NEXT activity would help stem cell aging remains unexplored.